|
Rizwan Haq, MD PhD |
Attending Physician, Medical Oncology, Dana-Farber Cancer Institute
Assistant Professor, Harvard Medical School
Education
Medical Oncology, Dana-Farber Cancer Institute/Partners CancerCare, 2008
Internal Medicine, Johns Hopkins Hospital, 2006.
MD PhD, Ontario Cancer Institute, University of Toronto, Toronto Canada 2003.
Dr. Haq is a physician-scientist who specializes in metastatic melanoma. He received his BSc, MD and PhD at the University of Toronto and the Ontario Cancer Institute with various honors. His internal medicine training was in the Osler Housestaff Training Program at Johns Hopkins Hospital, followed by fellowship training in oncology at Dana-Farber/Harvard Cancer Care. At the completion of his clinical training, he was a post-doctoral fellow with Dr David E. Fisher (Massachusetts General Hospital). He has been a contributing author of numerous publications, including those published in Cancer Cell, Nature, Proceedings of the National Academy of Sciences USA. Some of his research work has received coverage in the press. At Dana-Farber Cancer Institute, Dr Haq devotes part of his time to developing the next generation of melanoma therapeutics and translating them to innovative investigator-initiated clinical trials. His clinical practice is dedicated to patients with melanoma.
Dana-Farber Physician Profile
Dana-Farber Researcher Profile
Assistant Professor, Harvard Medical School
Education
Medical Oncology, Dana-Farber Cancer Institute/Partners CancerCare, 2008
Internal Medicine, Johns Hopkins Hospital, 2006.
MD PhD, Ontario Cancer Institute, University of Toronto, Toronto Canada 2003.
Dr. Haq is a physician-scientist who specializes in metastatic melanoma. He received his BSc, MD and PhD at the University of Toronto and the Ontario Cancer Institute with various honors. His internal medicine training was in the Osler Housestaff Training Program at Johns Hopkins Hospital, followed by fellowship training in oncology at Dana-Farber/Harvard Cancer Care. At the completion of his clinical training, he was a post-doctoral fellow with Dr David E. Fisher (Massachusetts General Hospital). He has been a contributing author of numerous publications, including those published in Cancer Cell, Nature, Proceedings of the National Academy of Sciences USA. Some of his research work has received coverage in the press. At Dana-Farber Cancer Institute, Dr Haq devotes part of his time to developing the next generation of melanoma therapeutics and translating them to innovative investigator-initiated clinical trials. His clinical practice is dedicated to patients with melanoma.
Dana-Farber Physician Profile
Dana-Farber Researcher Profile